Actinium Pharmaceuticals, Inc — Institutional Ownership
Which tracked institutions hold ATNM, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
10
Funds holding
$610150
Total value held
Buying
4 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $387978 | 395896 | +24686 | +6.65% |
| 2 | State Street Corp | $119771 | 122215 | -4000 | -3.17% |
| 3 | Northern Trust Corp | $68348 | 69743 | -6112 | -8.06% |
| 4 | Wells Fargo & Company/Mn | $19404 | 19800 | — | Held |
| 5 | Ubs Group Ag | $6623 | 6758 | +6758 | NEW BUY |
| 6 | Morgan Stanley | $6214 | 6341 | -7256 | -53.36% |
| 7 | Jpmorgan Chase & Co | $1479 | 1494 | — | Held |
| 8 | Barclays Plc | $199 | 203 | +203 | NEW BUY |
| 9 | Federated Hermes, Inc. | $134 | 137 | +137 | NEW BUY |
| 10 | Royal Bank Of Canada | $0 | 45 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.